抗高血压药物和勃起功能障碍:专注于β抑制剂
G Corona1, W Vena2,3, A Pizzocaro4
1Endocrinology Unit, Maggiore Hospital, Azienda-Usl Bologna, Bologna, Italy.
Endocrine
|September 13, 2024
概括
某些血压药物可以导致勃起功能障碍 (ED),其中β-阻断剂 (BBs) 是最常见的. 患者和医生之间的公开沟通是管理潜在的性副作用的关键.
科学领域:
- 药理学和泌尿病学 药理学和泌尿病学
- 心血管医学 心血管医学
背景情况:
- 高血压的管理往往涉及药物与潜在的副作用.
- 勃起功能障碍 (ED) 是一个问题,其与抗高血压药物的联系受到争论.
- 特定的药物类别,包括 thiazides 和β-阻断剂 (BBs),已被涉及.
研究的目的:
- 批判性地分析有关抗高血压药物的现有证据及其与ED的关联.
- 为这些药物对勃起功能障碍的真正贡献提供基于证据的总结.
主要方法:
- 对Medline,Embase和Cochrane数据库进行了全面的叙事审查.
- 具体的系统性审查侧重于β-阻断剂 (BBs) 对勃起功能障碍的影响.
主要成果:
- 中心作用药物 (克洛尼丁,α-甲基多巴) 已经记录了对勃起功能的负面影响.
- ACE 抑制剂 (ACEis),ARB 和 CCB 对勃起功能表现出中性到积极的影响.
- 根据最近的证据, thiazides 似乎不会对勃起功能产生负面影响; BBs 仍然与 ED 最相关,尽管 nebivolol 可能会提供更好的结果.
结论:
- 在高血压患者中,应该定期评估性功能.
- 开放的患者与医生的对话对于管理潜在的药物副作用至关重要.
- 有效的管理策略可以克服与抗高血压治疗相关的负面性结果.
相关概念视频
01:28Antihypertensive Drugs: Types of β-Blockers
603
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
603
01:17Antihypertensive Drugs: Action of β1 Blockers
320
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
320
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
543
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
543
01:22Heart Failure Drugs: β-Blockers
321
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
321
01:16Antianginal Drugs: Nitrates and β-Blockers
543
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
543
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
559
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
559